Company Badge
USPTO Data Jan 1 1976 - Jan 6 2026
19 Patents
#62 in Boulder, CO
#330 in Colorado
#16,635 in US
#31,731 in the World
Nivalis Therapeutics, Inc.
Forward Citations = 37
6 inventors:
Boulder, CO, United States of America
Nivalis Therapeutics, Inc.
CIPO Patents = 1
EPO Patents = 5
Forward Citations = 37
Loading Chart...
Loading Chart...
6 inventors (with patents filed for the assignee):
Jian Qiu (19 out of 38 patents)
Xicheng David Sun (19 out of 49 patents)
Adam Stout (8 out of 10 patents)
4. Jan William Wasley (6 out of 30 patents)
5. Sarah A Strong (5 out of 24 patents)
6. Gary Joseph Rosenthal (5 out of 18 patents)
19 patents:
1. 9856219 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2018-01-02),
2. 9814700 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2017-11-14),
5. 9498466 - Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents (2016-11-22),
6. 9433618 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2016-09-06),
8. 9315462 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors (2016-04-19),
Nivalis Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapeutics for people with cystic fibrosis (CF). Their mission is to improve the lives of CF patients by discovering and developing novel treatments that target the underlying cause of the disease. Nivalis Therapeutics is dedicated to advancing the understanding and treatment options for CF through extensive research and strategic collaborations with leading scientific institutions and healthcare partners.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
1 patent (CIPO):
Please report any incorrect information to support@idiyas.com
5 patents (EPO):
Please report any incorrect information to support@idiyas.com